Benchmark helps deliver improved healthcare products and welfare services to the global aquaculture and livestock industries. Rising demand from clients for its products and services to manage sustainability practice and performance underlines BMK's opportunity for significant organic and external growth.

30 Nov 2022

Benchmark Holdings - FY Results - Investor Presentation video - 30 November 2022

Benchmark Holdings plc, the aquaculture biotechnology company, conducted an investor presentation following publication of their Full Year results for the year ended 30 September 2022.

Trond Williksen, CEO, and Septima Maguire, CFO ran investors through operational highlights for each key division (Genetics, Advanced Nutrition, Health) and provided a detailed financial review. Management discussed their forthcoming Oslo listing, touched on the possible impact of the Norway salmon tax proposal, and answered a range of investor questions.

The full video is divided into chapters as below:
0:00:03 Introduction & FY22 highlights
0:05:13 Euronext Growth Oslo listing / placing & retail offer
0:06:20 Operational highlights by division
0:16:15 Financial Review
0:30:32 Strategy & Outlook
0:35:36 Questions & Answers

Return to Benchmark Holdings

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 2nd Floor, Park House, 16-18 Finsbury Circus, London, EC2M 7EB

Website design & development by Breckenridge